Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
Scheen, André; Letiexhe, Michel; Lefebvre, Pierre
1999 • In Diabetes and Metabolism, 25 (2), p. 157-62
Adult; Basal Metabolism; Blood Glucose/metabolism; Diabetes Mellitus, Type 1/blood/drug therapy; Drug Administration Schedule; Eating/physiology; Female; Humans; Hypoglycemic Agents/administration & dosage; Insulin/administration & dosage; Male; Postprandial Period
Abstract :
[en] The present study aimed at investigating the influence of the time interval between injection of regular insulin and meal ingestion on postprandial glucose changes and overall blood glucose control in patients with type 1 diabetes on intensive insulin therapy. Fifteen C-peptide negative subjects were submitted, in a randomized order, to two 6-week treatment periods in which regular insulin was injected either 5 minutes or 30 minutes before each of the three main meals, in combination with a bedtime NPH insulin injection. The changes in plasma glucose excursions following a breakfast test (Cmax, Tmax, Cmin, Tmin, AUC0-240 min) were similar in the two experimental protocols. Furthermore, no significant changes were observed in daily insulin dosages nor in glucose profiles obtained using home blood glucose monitoring. Only a tendency to a greater 90-minutes postprandial increase in blood glucose levels was observed when regular insulin was injected 5 minutes rather than 30 minutes before meal. Glycated haemoglobin levels were similar after each treatment period (7.6 +/- 0.2% versus 7.5 +/- 0.2%; NS) and no differences in the incidence or severity of hypoglycaemic episodes were noticed between the two insulin schemes. In conclusion, in type 1 diabetic patients who are rather well controlled with a basal-bolus insulin scheme, the injection of regular insulin 30 minutes before each main meal provides no significant advantage as compared to the injection of regular insulin 5 minutes before meal.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André ; Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Letiexhe, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Lefebvre, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Language :
English
Title :
Minimal influence of the time interval between injection of regular insulin and food intake on blood glucose control of type 1 diabetic patients on a basal-bolus insulin scheme.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
Buyscchaert M. Optimized insulin delivery: achievements and limitations. Diab Metab, 1989, 15, 188-203.
Scheen AJ, Lefèbvre PJ. Treatment of diabetes mellitus. In: European Textbook of Clinical Pharmacology. Sirtori, Ed, McGraw-Hill, 1999, in press.
Anderson JH, Brunelle RL, Koivisto VA, Pfützner A, Trautmann ME, Vignati L, DiMarchi R, and the Multicenter Insulin Lispro Study Group. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Diabetes, 1997, 46, 265-270.
Sackey AH, Jefferson IG. Interval between insulin injection and breakfast in diabetes. Arch Dis Child, 1994, 71, 248-250.
Witt MF, White NH, Santiago JV. Roles of site and timing of the morning insulin injection in type 1 diabetes. J Pediatrics, 1983, 103, 528-533.
Kinmonth AL, Baum JD. Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children. Br Med J, 1980, 280, 604-606.
Lean MEJ, Ng LL, Tennison BR. Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. Br Med J, 1985, 290, 105-108.
Patrick AW, Collier A, Matthews DM, Macintyre CCA, Clarke BF. The importance of the time interval between insulin injection and breakfast in determining postprandial glycaemic control - A comparison between human and porcine insulin. Diabetic Med, 1988, 5, 32-35.
Kraegen EW, Chisholm DJ, McNamara ME. Timing of insulin delivery with meals. Horm Metab Res, 1981, 13, 365-367.
Siddharth N, Pathar RB. Importance of timing of preprandial subcutaneous insulin injection in the management of diabetes mellitus. Diabetes Res Clin Pract, 1988, 5, Suppl 1.
Christensen O, Rosenfalck AM, Dejgaard A, Hilsted J. Insulin injection at meal time or 30 minutes before: effects on metabolic control in IDDM patients. Endocrinol Metab, 1997, 4, 403-408.
Lefèbvre PJ, Luyckx AS. The breakfast tolerance test: a return to physiology. Diab Metab, 1976, 2, 15-19.
Boz M, Gérard P, Scheen AJ, Lefèbvre PJ, Castillo MJ. Détermination rapide par immunodosage de l'hémoglobine glyquée sur sang capillaire comparée à une méthode d'affinité pour le boronate et capture d'ions sur sang veineux. Ann Biol Clin, 1997, 55, 139-144.
Hills M, Armitrage P. The two - period cross-over clinical trial. Br J clin Pharmac, 1979, 8, 7-20.
Buysschaert M, Maes M, Hermans MP. Traitement et contrôle glycémique de 1200 diabétiques inscrits dans les conventions INAMI "diabète". Acta Clin Belgica, 1997, 52, 211-218.
Nolte MS, Poon V, Grodsky GM, Forsham PH, Karam JH. Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins. Diabetes, 1983, 32, 1177-1181.
Heine RJ, Bilo HJG, Fonk T, van der Veen EA, van der Meer J. Absorption kinetics and action profiles of mixtures of short-and intermediate-acting insulins. Diabetologia, 1984, 27, 558-562.
Heinemann L, Starke AA, Hohmann A, Berger M. Timing between the subcutaneous administration of insulin and consumption of a carbohydrate rich meal. Horm Metab Res, 1992, 26 (Suppl), 137-139.
Dimitriadis GD, Gerich JE. Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care, 1983, 6, 374-377.
Howey DC, Bowsher RR, Brunelle RL, et al. [Lys(B28), Pro(B29)]-human insulin: Effect of injection time on postprandial glycemia. Clin Pharmacol Ther, 1995, 58, 459-469.
Torlone E, Pampanelli S, Lalli C, et al. Effects of the short-acting insulin analog [Lys(B28), Pro(B29)] on postprandial glucose control in IDDM. Diabetes Care, 1996, 19, 945-952.
Garg SK, Carmain JA, Braddy KC, et al. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabetic Med, 1996, 13, 47-52.
Del Sindaco P, Ciofetta M, Lalli C, et al. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabetic Med, 1998, 15, 592-600.
Galloway JA, Spradlin CT, Nelson RL, Wentworth SM, Davidson JA, Swarner JL. Factors influencing the absorption, serum concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care, 1981, 5, 366-376.
Binder C, Lauritzen T, Faber O, Pramming S. Insulin pharmacokinetics. Diabetes Care, 1984, 7, 188-199.
Scheen AJ. Pharmacocinétique de l'insuline administrée par voie sous-cutanée. Application au traitement par pompe portable. Diab Metab, 1989, 15, 128-138.
Lefèbvre PJ, Scheen AJ. Glucose metabolism and the postprandial state. Eur J Clin Invest, 1999, 29 (Suppl. 2, 1-6).
